Role of DNA aneuploidy, overexpression of p53 gene product, and cellular proliferation in the progression of gastric cancer

Communications in Clinical Cytometry

Volumn 38, Issue 3, 1999, Pages 111-117

  Sugai, Tamotsu ^a   Nakamura, Shin Ichi ^a   Uesugi, Noriyuki ^a   Habano, Wataru ^a   Yoshida, Toru ^a   Tazawa, Hideki ^a   Orii, Seishi ^a   Suto, Takayuki ^a   Itoh, Chuichi ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell proliferation; DNA ploidy; Gastric cancer; p53

Indexed keywords

GENE PRODUCT; KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

AGED; AGED, 80 AND OVER; ANEUPLOIDY; CELL DIVISION; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033564893     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19990615)38:3<111::AID-CYTO4>3.0.CO;2-T     Document Type: Article

References (33)

1. Battifora H. p53 immunohistochemistry: a word of caution. Hum Pathol 1994;25:435-436.
2. Bosari S, Viale G, Roncalli M, Graziani D, Borsani G, Lee AKC, Coggi G. p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol 1995;147:790-798.
3. Brito MJ, Williams H, Thompson H, Fillip M. Expression of p53 in early (T1) gastric carcinoma and precancerous adjacent mucosa. Gut 1994;35:1697-1700.
4. Carder P, Wyllie AH, Purdie C, Morris RG, White S, Piris J, Colin CB. Stabilized p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene 1993;8:1397-1401.
5. Cavenee WK, Dryja TP, Phillips RA, Bendict WF, Godbout R, Gallie BL, Murphree AL, Sreong LC, White RL. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983;305:779-784.
6. de Aretxabala X, Yonemura Y, Sugiyama K, Kamata T, Konishi K, Miwa K, Miyazaki I. DNA ploidy in early gastric cancer and its relationship to prognosis. Br J Cancer 1988;58:81-84.
7. Fontanini G, Vignati S, Bigini D, Merlo GR, Ribecchini A, Angeletti CA, Basolo F, Pingitore R, Bevilacqua G. Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. J Pathol 1994;174:23-31.
8. Giaretti W, Danova M, Geido E, Mazzini G, Sciallero S, Aste H, Scivetti F, Riccardi A, Marsano B, Merlo F, d'Amore ESG. Flow cytometric DNA index in the prognosis of colorectal cancer. Cancer 1991;67:1921-1927.
9. Gleeson CM, Sloan IM, McManus DT, Maxwell P, Arthur K, McGuigan JA, Ritchie A, Russell SE. Comparison of p53 and DNA content abnormalities in adenocarcinoma of the esophagus and gastric cardia. Br J Cancer 1998;77:277-286.
10. Hall PA, Levison DA. Review: assessment of cell proliferation in histological material. J Clin Pathol 1990;43:184-192.
11. Hongyo T, Buzard GS, Palli D, Weghorst CM, Amorosi A, Galli M, Caporaso NE, Fraumeni JF, Rice JM. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Cancer Res 1995;55:2665-2672.
12. Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study, 12th edition. Tokyo: Kanehara-shuppan; 1993. p 64-89.
13. Kallioniemi O-P. Comparison of fresh and paraffin embedded tissue as starting material for DNA flow cytometry and evaluation of intratumoral heterogeneity. Cytometry 1988;9:164-169.
14. Kimura H, Yonemura Y. Flow cytometric analysis of nuclear DNA content in advanced gastric cancer and its relationship with prognosis. Cancer 1991;67:2588-2593.
15. Lauren P. The two histological main types of gastric carcinomas: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Immunol Scand 1965;64:31-49
16. Lewin KJ, Appelman HD. Tumors of the esophagus and stomach, 3rd series. Washington, DC: Armed Forces Institute of Pathology; 1995. p 255-313.
17. Macartney IC, Camplejohn RS. DNA flow cytometry of histological material from dysplastic lesions of human gastric mucosa. J Pathol 1986;150:113-118
18. Mccormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 1993;22:355-360.
19. Meling GI, Rognum TO, Clausen OPF, Chen Y, Lunde OC, Schlichting E, Wiig JN, Hognestad J, Bakka A, Havig Ø, Bergan A. Association between DNA ploidy pattern and cellular atypia in colorectal carcinomas - a new clinical application of DNA flow cytometric study? Cancer 1990;67:1642-1649.
20. Meling GI, Lothe RA, Borresan AL, Graue C, Hauge S, Clausen OPF, Rognum TO. The TP 53 tumor suppressor gene in colorectal carcinomas. II. Relation to DNA ploidy pattern and clinicopathological variables. Br J Cancer 1993;67:93-98.
21. Muller W, Borchard F. Prognostic influence of p53 expression in gastric cancer. J Pathol 1996;178:255-258.
22. Muller W, Schneiders A, Meier S, Hommel G, Gabbert HE. Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma. Br J Cancer 1996;74:759-756.
23. Purdie CA, O'Grady J, Piris J, Wyllie AH, Bird CC. p53 expression in colorectal tumors. Am J Pathol 1991;138:807-813.
24. Quinn CM, Wright NA. The clinical assessment of proliferation and growth in human tumors: evaluation of methods and applications as prognostic variables J Pathol 1990;160:93-102.
25. Ramires M, David L, Leitao D, Seixas M, Sonsonctty F, Sobrinho-Simoes M. Ki-67 labelling index in gastric carcinomas. An immunohistochemical study using double staining for the evaluation of the proliferative activity of diffuse-type carcinomas. J Pathol 1997;182: 62-67.
26. Sasaki K, Hashimoto T, Kawachino K, Takahashi M. Intratumoral regional differences in DNA ploidy of gastrointestinal carcinomas. Cancer 1988;62:2569-2575.
27. Schlemper RJ, Itabashi M, Kalo Y, Lewin KJ, Reddell RH, Shimoda T, Sipponen P, Stole M, Watanabe H. Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet 1997;349:1725-1729.
28. Serth J, Kuczyk MA, Bokemeyer C, Hervatin C, Nafe R, Tan HK, Jonas U. p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. Br J Cancer 1995;71:201-205.
29. Sugihara H, Hattori T, Fujita S, Hirose K, Fukuda M. Regional ploidy variations in signet ring cell carcinomas of the stomach. Cancer 1990;65:122-129.
30. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S. p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 1993;54:759-764.
31. Watanabe A, Korenaga D, Maehara Y, Sugimachi K. Nuclear DNA content, tumor cell aggregation, and metastatic events in patients with poorly differentiated adenocarcinoma of the stomach. Cancer 1991;68:815-820.
32. Wright PA, Qurike P, Attanoos R, Williams GT. Molecular pathology of gastric carcinoma: progress and prospects. Hum Pathol 1992;23:848-859.
33. Wyatt JI, Quirke P, Ward DC, Clayden AD, Dixon MF, Johnston D, Bird CC. Comparison of histopathological and flow cytometric parameters in prediction of prognosis in gastric cancer. J Pathol 1989;158:195-201.